AZRX

AzurRx BioPharma (AZRX)

AzurRx BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AZRX
DateTimeSourceHeadlineSymbolCompany
12/06/20219:26AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
11/29/20214:45PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
11/19/20215:01PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a) NASDAQ:AZRXAzurRx BioPharma Inc
11/15/20215:32PMEdgar (US Regulatory)Quarterly Report (10-q) NASDAQ:AZRXAzurRx BioPharma Inc
11/10/20215:20PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
11/09/20215:24PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) NASDAQ:AZRXAzurRx BioPharma Inc
11/09/20214:42PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
09/28/20215:16PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
09/21/202112:47PMGlobeNewswire Inc.AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today NASDAQ:AZRXAzurRx BioPharma Inc
09/14/20215:13PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
09/14/20217:30AMGlobeNewswire Inc.AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma NASDAQ:AZRXAzurRx BioPharma Inc
09/13/20216:00AMGlobeNewswire Inc.AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications NASDAQ:AZRXAzurRx BioPharma Inc
09/10/20214:06PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
09/10/202112:45PMGlobeNewswire Inc.AzurRx BioPharma Announces Reverse Stock Split NASDAQ:AZRXAzurRx BioPharma Inc
09/10/20218:30AMGlobeNewswire Inc.AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections NASDAQ:AZRXAzurRx BioPharma Inc
09/09/20218:30AMGlobeNewswire Inc.AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections NASDAQ:AZRXAzurRx BioPharma Inc
09/07/20214:30PMGlobeNewswire Inc.AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference NASDAQ:AZRXAzurRx BioPharma Inc
08/18/20217:05AMGlobeNewswire Inc.AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI) NASDAQ:AZRXAzurRx BioPharma Inc
08/17/20217:00AMGlobeNewswire Inc.AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819 NASDAQ:AZRXAzurRx BioPharma Inc
08/16/20214:49PMEdgar (US Regulatory)Quarterly Report (10-q) NASDAQ:AZRXAzurRx BioPharma Inc
08/16/20214:22PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
08/16/20218:00AMGlobeNewswire Inc.AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors NASDAQ:AZRXAzurRx BioPharma Inc
08/12/20217:00AMGlobeNewswire Inc.AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections NASDAQ:AZRXAzurRx BioPharma Inc
08/10/20217:00AMGlobeNewswire Inc.AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections NASDAQ:AZRXAzurRx BioPharma Inc
07/27/20215:26PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
07/27/20214:30PMGlobeNewswire Inc.AzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Shares NASDAQ:AZRXAzurRx BioPharma Inc
07/23/20216:05AMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) NASDAQ:AZRXAzurRx BioPharma Inc
07/23/202112:08AMSeeking AlphaAzurRx Bio secures $5M capital raise NASDAQ:AZRXAzurRx BioPharma Inc
07/22/20219:40PMGlobeNewswire Inc.AzurRx BioPharma Increases Previously Announced Bought Deal to $5.0 Million NASDAQ:AZRXAzurRx BioPharma Inc
07/22/20215:05PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) NASDAQ:AZRXAzurRx BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:AZRX
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20211209 06:43:10